Table 2 Univariable analysis of postoperative early recurrence
Early recurrence (n = 23) | Early non-recurrence(n = 169) | P | |
|---|---|---|---|
Age (years old) | 62.74 ± 10.94 | 61.20 ± 11.34 | 0.457 |
Weight(kg) | 70.13 ± 8.83 | 69.98 ± 12.45 | 0.954 |
Duration of atrial fibrillation (months) | 86.24 ± 119.42 | 42.17 ± 66.20 | 0.020* |
Male | 15(65.2%) | 126(74.6%) | 0.341 |
Female | 8(34.8%) | 43(25.4%) | |
Heart failure | 3(13.0%) | 18(10.7%) | 1.000 |
Hypertension | 10(43.5%) | 67(39.6%) | 0.725 |
Diabetes | 4(17.4%) | 32(18.9%) | 1.000 |
Coronary heart disease | 4(17.4%) | 20(11.8%) | 0.674 |
Stroke history | 3(13.0%) | 15(8.9%) | 0.793 |
Peripheral vascular disease | 6(26.1%) | 40(23.7%) | 0.799 |
CHA2DS2-VASc score | 2.35 ± 2.08 | 1.99 ± 1.65 | 0.555 |
LA diameter(mm) | 46.54 ± 6.64 | 45.43 ± 6.02 | 0.469 |
EF(%) | 60.91 ± 9.53 | 60.74 ± 8.57 | 0.790 |
NT-proBNP(pg/mL) | 783.53 ± 689.68 | 779.00 ± 741.13 | 0.907 |
Success rate of conversion using ibutilide | 10(43.5%) | 105(62.1%) | 0.087 |
Failure rate of conversion using ibutilide | 13(56.5%) | 64(37.9%) |